Cost–utility analysis of Social Stories™ for children with autism spectrum disorder in mainstream primary schools: results from a randomised controlled trial
Open Access
- 3 June 2024
- journal article
- research article
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 10 (4) , e123
Abstract
Background: One in 57 children are diagnosed with autism in the UK, and the estimated cost for supporting these children in education is substantial. Social Stories™ is a promising and widely used intervention for supporting children with autism in schools and families. It is believed that Social Stories™ can provide meaningful social information to children that can improve social understanding and may reduce anxiety. However, no economic evaluation of Social Stories has been conducted. Aims: To assess the cost-effectiveness of Social Stories through Autism Spectrum Social Stories in Schools Trial 2, a multi-site, pragmatic, cluster-randomised controlled trial. Method: Children with autism who were aged 4–11 years were recruited and randomised (N = 249). Costs measured from the societal perspective and quality-adjusted life-years (QALYs) measured by the EQ-5D-Y-3L proxy were collected at baseline and at 6-month follow-up for primary analysis. The incremental cost-effectiveness ratio was calculated, and the uncertainty around incremental cost-effectiveness ratios was captured by non-parametric bootstrapping. Sensitivity analyses were performed to evaluate the robustness of the primary findings. Results: Social Stories is likely to result in a small cost savings (–£191 per child, 95% CI −767.7 to 337.7) and maintain similar QALY improvements compared with usual care. The probability of Social Stories being a preferred option is 75% if society is willing to pay £20 000 per QALY gained. The sensitivity analysis results aligned with the main study outcomes. Conclusions: Compared with usual care, Social Stories did not lead to an increase in costs and maintained similar QALY improvements for primary-aged children with autism.Keywords
This publication has 25 references indexed in Scilit:
- Association of Race/Ethnicity and Social Disadvantage With Autism Prevalence in 7 Million School Children in EnglandJAMA Pediatrics, 2021
- Costs of Autism Spectrum Disorders in the United Kingdom and the United StatesJAMA Pediatrics, 2014
- Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHDThe European Journal of Health Economics, 2013
- Development of the EQ-5D-Y: a child-friendly version of the EQ-5DQuality of Life Research, 2010
- Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational studyQuality of Life Research, 2010
- Social Story™ Interventions for Students with Autism Spectrum Disorders: A Meta-AnalysisJournal of Autism and Developmental Disorders, 2010
- Social Stories™ for Children with DisabilitiesJournal of Autism and Developmental Disorders, 2006
- Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utilityHealth Economics, 2004
- Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questionsHealth Economics, 2004
- Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysisHealth Economics, 2002